• 7898 Citations
  • 45 h-Index
1988 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Editorial
Editorial

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?

Kim, D. Y., 2017 Jun 1, In : Clinical and Molecular Hepatology. 23, 2, p. 123-124 2 p.

Research output: Contribution to journalEditorial

Open Access

Estimation of direct medical costs related to chronic hepatitis C: A rationale for early antiviral therapy

Kim, D. Y., 2017 Nov, In : Gut and liver. 11, 6, p. 745-746 2 p.

Research output: Contribution to journalEditorial

1 Citation (Scopus)

Hepatitis C viral kinetics as a determinant of stopping pegylated interferon and ribavirin in genotype 1 infection

Kim, D. Y., 2014 Jul, In : Gut and liver. 8, 4, p. 335-336 2 p.

Research output: Contribution to journalEditorial

Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma

Han, S. & Kim, D. Y., 2020 Jul, In : Clinical and Molecular Hepatology. 26, 3, p. 305-308 4 p.

Research output: Contribution to journalEditorial

Open Access
1 Citation (Scopus)

Staging for hepatocellular carcinoma in light of tumor heterogeneity: Time to change or update?

Kim, D. Y. & Han, K. H., 2018 Jun, In : Hepatology. 67, 6, p. 2076-2078 3 p.

Research output: Contribution to journalEditorial

1 Citation (Scopus)